This MedLibrary.org supplementary page on Norepinephrine-dopamine reuptake inhibitor is provided directly from the open source Wikipedia as a service to our readers. Please see the note below on authorship of this content, as well as the Wikipedia usage guidelines. To search for other content from our encyclopedia supplement, please use the form below:
Related Sponsors
A Norepinephrine-dopamine reuptake inhibitor is a class of drugs that is both:
An example is Bupropion.[1] A drug related to Bupropion, Radafaxine, is presently in clinical trials.
References
- ^ Stephen M. Stahl, M.D., Ph.D.; et al (2004). "A Review of the Neuropharmacology of Bupropion, a Dual Norepinephrine and Dopamine Reuptake Inhibitor" (pdf). Journal of Clinical Psychiatry; 6(04) 159-166 2004 PHYSICIANS POSTGRADUATE PRESS, INC. Retrieved on 2006-09-02.
 |
This medical treatment article is a stub. You can help Wikipedia by expanding it. |
|
|||||||||||||||||||||||||||||||
Wikipedia content modification information:
- This page was last modified on 22 September 2007, at 20:48.
Wikipedia Authorship and Review
Wikipedia content provided here is not reviewed directly by MedLibrary.org. Wikipedia content is authored by an open community of volunteers and is not produced by or in any way affiliated with MedLibrary.org.
Wikipedia Usage Guidelines
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article on "Norepinephrine-dopamine reuptake inhibitor".
The URL for this specific entry is:
All Wikipedia text is available under the terms of the GNU Free Documentation License. (See Copyrights for details). Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc.